The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radiotherapy (BSCPED-05 international multicentric trial, EUDRACT 2005-003100-11) in 2009 when we decided to explore the activity of the same combination plus vinorelbine (see the paper for the rationale).
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood (Journal of Neuro-Oncology, (2014), 10.1007/s11060-014-1428-z) / M. Massimino, V. Biassoni, R. Miceli, E. Schiavello, M. Warmuth-Metz, P. Modena, M. Casanova, E. Pecori, F. Giangaspero, M. Antonelli, F.R. Buttarelli, P. Potepan, B. Pollo, R. Nunziata, F. Spreafico, M. Podda, A. Anichini, C.A. Clerici, I. Sardi, L. De Cecco, U. Bode, F. Bach, L. Gandola. - In: JOURNAL OF NEURO-ONCOLOGY. - ISSN 0167-594X. - 138:3(2018 Jul 01), pp. 679-680. [10.1007/s11060-018-2893-6]
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood (Journal of Neuro-Oncology, (2014), 10.1007/s11060-014-1428-z)
C.A. Clerici;
2018
Abstract
The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radiotherapy (BSCPED-05 international multicentric trial, EUDRACT 2005-003100-11) in 2009 when we decided to explore the activity of the same combination plus vinorelbine (see the paper for the rationale).File | Dimensione | Formato | |
---|---|---|---|
Massimino2018_Article_CorrectionToResultsOfNimotuzum.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
512.68 kB
Formato
Adobe PDF
|
512.68 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.